PARK PRACTICE — All Prescriptions & Medications — Page 10
Practice Code: G81104 | EASTBOURNE, BN22 9PQ
Showing results 451-500 of 700
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Pimecrolimus | 38 | 1,480 | £910 | +124.4% ▲ |
| Other individually formulated bought in preparations | 37 | 654 | £210 | +13.2% ▲ |
| 37 | 310 | £120 | +27.8% ▲ | |
| Aclidinium bromide/formoterol | 36 | 36 | £1.1K | +2.4% ▲ |
| Atomoxetine hydrochloride | 34 | 994 | £2.0K | +0.6% vs avg |
| Exenatide | 34 | 136 | £2.5K | +93.9% ▲ |
| Leuprorelin acetate | 34 | 34 | £7.4K | -26.6% ▼ |
| 34 | 190 | £530 | +369.3% ▲ | |
| 34 | 960 | £6.3K | +168.2% ▲ | |
| Linaclotide | 33 | 952 | £1.2K | +80.6% ▲ |
| Flupentixol hydrochloride | 33 | 2,520 | £156 | +0.7% vs avg |
| Hyoscine hydrobromide | 33 | 2,892 | £445 | -3.4% ▼ |
| Diamorphine hydrochloride (Systemic) | 33 | 305 | £890 | +395.3% ▲ |
| Fosfomycin trometamol | 33 | 45 | £208 | +16.0% ▲ |
| Clindamycin phosphate | 33 | 1,260 | £337 | +100.6% ▲ |
| 33 | 2,433 | £4.6K | +87.2% ▲ | |
| Tranylcypromine sulfate | 32 | 861 | £14.9K | +180.6% ▲ |
| Clindamycin hydrochloride | 32 | 2,002 | £667 | +219.6% ▲ |
| 32 | 330 | £1.0K | +57.2% ▲ | |
| 32 | 2,450 | £369 | -17.8% ▼ | |
| 32 | 1,590 | £5.2K | +31.4% ▲ | |
| Prasugrel | 31 | 1,288 | £265 | -1.4% vs avg |
| Tamsulosin and dutasteride hydrochloride | 31 | 866 | £369 | -11.3% ▼ |
| Other health supplement preparations | 31 | 476 | £49 | -34.7% ▼ |
| 31 | 334 | £748 | -21.2% ▼ | |
| 31 | 930 | £9.9K | +196.5% ▲ | |
| 31 | 5,700 | £736 | +74.5% ▲ | |
| 31 | 990 | £5.1K | +166.9% ▲ | |
| Propantheline bromide | 30 | 3,078 | £2.3K | +131.1% ▲ |
| Omega-3-acid ethyl esters | 30 | 1,680 | £812 | +42.0% ▲ |
| Oxazepam | 30 | 1,214 | £140 | +40.8% ▲ |
| Cinacalcet hydrochloride | 30 | 1,291 | £492 | +29.3% ▲ |
| Celecoxib | 30 | 1,320 | £74 | -54.6% ▼ |
| Cocois | 30 | 9,180 | £1.4K | +118.5% ▲ |
| 30 | 2,050 | £94 | -44.7% ▼ | |
| 30 | 2,920 | £9.4K | +33.9% ▲ | |
| Aclidinium bromide | 29 | 29 | £896 | +9.3% ▲ |
| Modafinil | 29 | 2,622 | £278 | +39.1% ▲ |
| Acamprosate calcium | 29 | 3,332 | £363 | -16.7% ▼ |
| Pivmecillinam hydrochloride | 28 | 349 | £185 | -46.7% ▼ |
| 28 | 412 | £849 | +8.1% ▲ | |
| 28 | 350 | £224 | -35.1% ▼ | |
| 28 | 1,880 | £539 | +171.1% ▲ | |
| Dronedarone hydrochloride | 27 | 2,312 | £2.6K | +86.9% ▲ |
| Eslicarbazepine acetate | 27 | 1,094 | £2.3K | +21.0% ▲ |
| Biphasic isophane insulin | 27 | 175 | £760 | -75.8% ▼ |
| Estradiol valerate | 27 | 2,772 | £230 | +38.2% ▲ |
| Exemestane | 27 | 1,324 | £1.2K | -16.9% ▼ |
| Light liquid paraffin | 27 | 13.8K | £249 | -20.7% ▼ |
| Ivermectin | 27 | 1,290 | £747 | +27.0% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.